Abstract
Trauma, shock, and sepsis are frequently complicated by coagulation disorders which contribute to the development of multiorgan failure [1]. Especially in trauma patients, intrinsic and extrinsic activation of the clotting cascade is started by the release of tissue factor and contact activation following vascular damage. In septic patients, lipopolysaccharides (LPS) accelerate procoagulant turnover by activating neutrophils and hence mediators like elastase or platelet activating factor (PAF), and factor XII. The application of cristalloids and colloids in order to maintain normovolemia further dilutes both the procoagulant and inhibitor potential of the plasmatic coagulation. Plasma factors and platelets are lost by traumatic, surgical or diffuse bleeding. However, with ongoing activation of the coagulation cascade, dilution and loss become less important compared to changes in the dynamics of procoagulant and inhibitor turnover.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Fourrier F, Chopin C, Goudemand J, et al. (1992) Septic shock, multiple organ failure, and disseminated intravascular coagulation. Chest 101: 816–823
Mammen EF, Miyakawa T, Phillips TF, et al. (1985) Human antithrombin concentrates and eperimental disseminated intravascular coagulation. Sem Thromb Hemost 11: 373–383
Flier JS, Underhill LH (1992) Molecular and cellular biology of blood coagulation. N Engl J Med 12: 800–806
Kaplan AP, Silverberg M (1987) The coagulation kinin pathway of human plasma. Blood 70: 1–15
Kwaan HC (1979) Fibrinolysis: A perspective. Prog Cardiovas Dis 21: 397–401
Marcum JA, Rosenberg RD (1984) Anticoagulantly active heparin-like molecules from vascular tissue. Biochem 23: 1730–1737
Esmon CT (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264: 4743–4746
Preissner KT (1990) Biological relevance of the protein C system and laboratory diagnosis of protein C and protein S deficiencies. Clin Sei 78: 351–364
Wencel-Drake JD, Plow EF, Zimmerman TS, Painter RG, Ginsberg MH (1984) Immunofluorescent localization of adhesive glycoproteins in resting and thrombin-stimulated platelets. Am J Pathol 115: 156–164
Niewiarowski S, Holt JC (1987) Biochemistry and physiology of secreted platelet proteins. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Hemostasis and thrombosis, 2nd edn. Lippincott, Philadelphia, pp 618–630
Zuckerman L, Cohen E, Vagher JP, et al. (1981) Comparison of thrombelastography with common coagulation tests. Thromb Haemost 46: 752–756
Mallett SV, Cox DJA (1992) Thrombelastography. Br J Anaesth 69: 307–313
Pelzer H, Schwarz A, Stuber W (1991) Determination of human Prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 65: 153–159
Pelzer H, Schwarz A, Heimburger N (1988) Determination of human thrombin-antithrombin III complex in plasma with an enzyme linked immunosorbent assay. Thromb Haemost 59: 101–106
Okamoto K, Takaki A, Takeda S, et al. (1992) Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: Determination of Prothrombin fragment 1+2 and other markers. Haemostasis 22: 17–24
Kambayashi J, Sakon M, Yokota M, et al. (1990) Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers. Thromb Res 60: 157–167
Wieding JU, Eisinger G, Köstering H (1989) Diagnostik der disseminierten intravasalen Gerinnung: Aussagekraft von löslichem Fibrin, D-Dimeren und Fibrin(-ogen)-Spaltprodukten. Klin Wochenschr 67:764–773
Song KS, Kim BS, Lee SY (1991) Diagnostic efficacy of D-dimer assay in evaluating disseminated intravascular coagulation. Thromb Haemost 65: 1235 (Abst)
Boisclair MD, Cane DA, Wilde JT, et al. (1990) A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: Thrombin-antithrombin complex, D-dimer, and figrinogen/fibrin fragment E antigen. Br J Haematol 74:471–479
Taylor FB, Emerson TE, Jordan R (1988) AT III prevents the lethal effects of Escherichia coli infusion in baboons. Circ Shock 26: 227–235
Schipper HG, Ten Cate JW (1982) Antithrombin JH transfusion in patients with hepatic cirrhosis. Br J Haematol 52: 25–33
Seitz R, Wolf M, Egbring R, Havemann VK (1989) The disturbance of hemostasis in septic shock: Role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution. Eur J Haematol 43:22–28
Blauhut B, Kramar H, Vinazzer M, et al. (1985) Substitution of antithrombin III in shock and DIC: A randomised study. Thromb Res 39:81–89
Riess H, Binsack T, Hiller E (1985) Protein C antigen in Prothrombin complex concentrates: Content, recovery, and half-life. Blut 50:303–306
Moore KL, Andreoli SP, Esmon NL, et al. (1987) Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 79: 124–130
Bevilacqua MP, Pober JS, Majeau GR, et al. (1986) Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin-1. Proc Natl Acad Sei USA 83: 4533–4537
Mann KG (1984) Membrane-bound enzyme complexes in blood coagulation. In: Spaet TH (ed) Progress in hemostasis and thrombosis. Grüne & Stratton, New York, pp 1–23
Archipoff G, Beretz A, Freyssinet JM, et al. (1991) Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following Stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester. Biochem J 273: 679–684
Stern EM, Esposito C, Gerlach H, et al. (1991) Endothelium and regulation of coagulation. Diabetes care 14: 160–166
Moncada S, Gryglewski R, Bunting S, et al. (1976) An enzyme isolated from arteries trans- forms Prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663–671
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Scherer, R., Kox, W.J. (1993). Consumptive Coagulopathies in the Critically III. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 1993. Yearbook of Intensive Care and Emergency Medicine 1993, vol 1993. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84904-6_58
Download citation
DOI: https://doi.org/10.1007/978-3-642-84904-6_58
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-56463-8
Online ISBN: 978-3-642-84904-6
eBook Packages: Springer Book Archive